WINTON GROUP Ltd bought a new position in Select Medical Holdings Co. (NYSE:SEM) in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 19,307 shares of the health services provider’s stock, valued at approximately $306,000.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in SEM. Parallel Advisors LLC lifted its position in Select Medical by 2,889.2% in the first quarter. Parallel Advisors LLC now owns 2,481 shares of the health services provider’s stock worth $35,000 after purchasing an additional 2,398 shares during the period. NumerixS Investment Technologies Inc lifted its position in Select Medical by 21.9% in the first quarter. NumerixS Investment Technologies Inc now owns 9,122 shares of the health services provider’s stock worth $126,000 after purchasing an additional 1,636 shares during the period. LPL Financial LLC lifted its position in Select Medical by 8.2% in the fourth quarter. LPL Financial LLC now owns 10,980 shares of the health services provider’s stock worth $169,000 after purchasing an additional 836 shares during the period. BBT Capital Management LLC acquired a new stake in Select Medical in the first quarter worth approximately $226,000. Finally, Two Sigma Advisers LP acquired a new stake in Select Medical in the fourth quarter worth approximately $244,000. Hedge funds and other institutional investors own 75.36% of the company’s stock.
A number of equities research analysts have weighed in on the company. Barclays restated a “hold” rating and issued a $16.00 target price on shares of Select Medical in a research report on Thursday, May 9th. ValuEngine upgraded Select Medical from a “sell” rating to a “hold” rating in a research report on Wednesday, May 22nd. JMP Securities upgraded Select Medical from a “market perform” rating to an “outperform” rating and set a $18.00 target price for the company in a research report on Friday, May 17th. Finally, TheStreet upgraded Select Medical from a “c+” rating to a “b-” rating in a research report on Thursday, June 27th. Four research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $16.67.
Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, August 1st. The health services provider reported $0.33 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.33. The company had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.34 billion. Select Medical had a return on equity of 14.26% and a net margin of 2.80%. The firm’s revenue was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.31 earnings per share. As a group, equities research analysts expect that Select Medical Holdings Co. will post 1.08 earnings per share for the current fiscal year.
Select Medical Company Profile
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Further Reading: Channel Trading
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEM).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.